Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04487470 · ClinicalTrials.gov registry record · NA
Impact of Cigar Flavor in Dual Users
A NA study, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT04487470: Completed NA study, sponsored by UConn Health.
NCT04487470 is a NA study that has completed, run by UConn Health. The registered enrollment target is 89 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04487470, a NA study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
The purpose of this study is to understand addiction to filtered cigars (FCs) compared to cigarettes in young adults, ages 21-34, who smoke both cigarettes and cigars. We are also looking to see if flavors, such as fruit or menthol, make FCs more addictive and if there are differences between men and women. Participants will receive 2 weeks supply of FCs, one week flavored and another week unflavored. You will be randomized (like flipping a coin) to which type of FC you will receive first. The study will: * take about 3-4 hours of your time per week over 3-5 weeks. * be conducted remotely by phone, video call, email, and mail. * require a smart phone to answer 5 quick surveys a day * you will need to answer 4 weekly surveys * take part in a weekly video or phone call with research staff * supply three saliva samples to be later tested for nicotine and other toxicants * and use a device to measure your carbon monoxide levels four times a day. You will be compensated for your time.
Primary Outcome
It is measured by the Cigarette Purchase Task, which will be adapted to assess these products. It is the hypothetical consumption of flavored cigars at increasing prices.
Interventions
- OTHER Flavored filtered cigars
- OTHER Unflavored filtered cigars
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2020-06-24 |
| Est. Completion | 2024-11-30 |
| Phase | NA |
What the finished NCT04487470 record still lists
NCT04487470 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Flavored filtered cigars is the first listed.
NCT04487470 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04487470 about?
NCT04487470 is a clinical study titled "Impact of Cigar Flavor in Dual Users". The purpose of this study is to understand addiction to filtered cigars (FCs) compared to cigarettes in young adults, ages 21-34, who smoke both cigarettes and cigars. We are also looking to see if flavors, such as fruit or menthol, make FCs more addictive and if there are differences between men an...
What is the current status of trial NCT04487470?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2020-06-24. Estimated completion is 2024-11-30.
What interventions are being tested in trial NCT04487470?
The interventions under investigation include: Flavored filtered cigars (OTHER), Unflavored filtered cigars (OTHER).
Who is sponsoring clinical trial NCT04487470?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04487470's enrollment target sits among peer trials
89 972nd of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI